山西證券(002500.SZ):控股子公司因樂視網證券虛假陳述糾紛被訴訟
格隆匯1月17日丨山西證券(002500.SZ)公佈,2022年1月13日,公司控股子公司中德證券有限責任公司(以下簡稱"中德證券")收到北京金融法院送達的民事起訴狀,案由為證券虛假陳述責任糾紛。上海君盈資產管理合夥企業(有限合夥)等兩千名原吿向北京金融法院對樂視網信息技術(北京)股份有限公司(以下簡稱"樂視網")等二十一名被吿提起民事訴訟,要求樂視網賠償因其虛假陳述行為造成的投資損失共計45.71億元,要求其他二十名被吿承擔連帶賠償責任。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.